22-MULTI-55-FP-PMC (FPI-2059-101): A Phase 1 Study of [225AC]-FPI-2059 In Adult Participants with NTSR1-Expressing Advanced, Metastatic and/or Recurrent Solid Tumours

Grants and Contracts Details

StatusActive
Effective start/end date12/20/2210/4/24

Funding

  • Medpace Inc: $29,398.00